Literature DB >> 6141221

Evidence for a selective processing of proenkephalin B into different opioid peptide forms in particular regions of rat brain and pituitary.

B R Seizinger, C Grimm, V Höllt, A Herz.   

Abstract

The distribution of five major products of proenkephalin B [dynorphin1-17, dynorphin B, dynorphin1-8, alpha-neo-endorphin and beta-neo-endorphin] was studied in regions of rat brain and pituitary. The distribution pattern of immunoreactive (ir) dynorphin B (= rimorphin) was found to be similar to that of ir-dynorphin1-17, with the highest concentrations being present in the posterior pituitary and the hypothalamus. HPLC and gel filtration showed the tridecapeptide dynorphin B to be the predominant immunoreactive species recognized by dynorphin B antibodies in all brain areas and in the posterior pituitary. In addition, two putative common precursor forms of dynorphin B and dynorphin1-17 with apparent molecular weights of 3,200 and 6,000 were detected in brain and the posterior pituitary. The 3,200 dalton species coeluted with dynorphin1-32 on HPLC. In contrast with all other tissues, anterior pituitary ir-dynorphin B and ir-dynorphin1-17 consisted exclusively of the 6,000 dalton species. Concentrations of dynorphin1-8 were several times higher than those of dynorphin1-17 in striatum, thalamus, and midbrain while posterior pituitary, hypothalamus, pons/medulla, and cortex contained roughly equal concentrations of these two opioid peptides. No dynorphin1-8 was detected in the anterior pituitary. Concentrations of beta-neo-endorphin were similar to those of alpha-neo-endorphin in the posterior pituitary. In contrast, in all brain tissues alpha-neo-endorphin was found to be the predominant peptide, with tissue levels in striatum and thalamus almost 20 times higher than those of beta-neo-endorphin. These findings indicate that differential proteolytic processing of proenkephalin B occurs within different regions of brain and pituitary. Moreover, evidence is provided that, in addition to the paired basic amino acids -Lys-Arg- as the "typical" cleavage site for peptide hormone precursors, other cleavage signals also seem to exist for the processing of proenkephalin B.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6141221     DOI: 10.1111/j.1471-4159.1984.tb02698.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.

Authors:  V K Shukla; S Lemaire
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

2.  Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra.

Authors:  R Riesenberg; C Nitsch
Journal:  Cell Tissue Res       Date:  1990-07       Impact factor: 5.249

3.  Isolation and structure of a C-terminally amidated nonopioid peptide, amidorphin-(8-26), from bovine striatum: a major product of proenkephalin in brain but not in adrenal medulla.

Authors:  D C Liebisch; E Weber; B Kosicka; C Gramsch; A Herz; B R Seizinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 4.  Five Decades of Research on Opioid Peptides: Current Knowledge and Unanswered Questions.

Authors:  Lloyd D Fricker; Elyssa B Margolis; Ivone Gomes; Lakshmi A Devi
Journal:  Mol Pharmacol       Date:  2020-06-02       Impact factor: 4.436

5.  Further studies on possible dynorphin involvement in the ovulatory luteinizing hormone surge in the proestrous rat.

Authors:  Qiang Zhang; Jennifer M McCoy; Robert V Gallo
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

6.  Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease.

Authors:  Xu Yue; Torsten Falk; Leslie A Zuniga; Lajos Szabò; Frank Porreca; Robin Polt; Scott J Sherman
Journal:  Brain Res       Date:  2011-07-23       Impact factor: 3.252

7.  Effect of prodynorphin-derived opioid peptides on the ovulatory luteinizing hormone surge in the proestrous rat.

Authors:  Qiang Zhang; Robert V Gallo
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

8.  Sequence and expression of the rat prodynorphin gene.

Authors:  O Civelli; J Douglass; A Goldstein; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Proenkephalin is processed in a projection-specific manner in the rat central nervous system.

Authors:  J D White; C M Gall; J F McKelvy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

10.  Differential effects of various opioid peptides on vasopressin and oxytocin release from the rat pituitary in vitro.

Authors:  D Maysinger; I Vermes; F Tilders; B R Seizinger; C Gramsch; V Höllt; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.